We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.3B
AUM Growth
-$168M
Cap. Flow
+$80.2M
Cap. Flow %
0.56%
Top 10 Hldgs %
50.75%
Holding
806
New
78
Increased
577
Reduced
108
Closed
39

Sector Composition

Rank Sector Weight
1 Energy 59.62%
2 Financials 3.1%
3 Materials 2.91%
4 Healthcare 2.65%
5 Industrials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
276
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$772K 0.01%
+30,897
New +$712K
FHI icon
277
Federated Hermes
FHI
$4.4B
$760K 0.01%
26,891
+1,379
+5% +$36.8K
MXIM
278
DELISTED
Maxim Integrated Products
MXIM
$749K 0.01%
16,684
+6,204
+59% +$285K
OSUR icon
279
OraSure Technologies
OSUR
$273M
$747K 0.01%
43,257
+111
+0.3% +$1.6K
MCK icon
280
McKesson
MCK
$98.5B
$739K 0.01%
4,491
+857
+24% +$130K
COR icon
281
Cencora
COR
$60.3B
$732K 0.01%
7,743
+1,390
+22% +$124K
LCI
282
DELISTED
Lannett Company, Inc.
LCI
$728K 0.01%
8,925
+480
+6% +$41.8K
MTD icon
283
Mettler-Toledo International
MTD
$26.8B
$721K 0.01%
1,225
+17
+1% +$9.31K
RVNC
284
DELISTED
Revance Therapeutics, Inc.
RVNC
$721K 0.01%
27,324
+2,793
+11% +$62.3K
KDNY
285
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$719K 0.01%
12,621
+1,062
+9% +$53.3K
ATVI
286
DELISTED
Activision Blizzard
ATVI
$718K 0.01%
12,469
+1,632
+15% +$90.1K
ILG
287
DELISTED
ILG, Inc Common Stock
ILG
$715K 0.01%
26,025
+68
+0.3% +$1.72K
FAF icon
288
First American
FAF
$7.66B
$712K 0.01%
15,925
+2,214
+16% +$93.6K
NDRM
289
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$711K 0.01%
23,771
+1,114
+5% +$28.9K
SNBR
290
DELISTED
Sleep Number
SNBR
$709K ﹤0.01%
19,986
+52
+0.3% +$1.55K
TKR icon
291
Timken Company
TKR
$9.82B
$706K ﹤0.01%
+15,256
New +$701K
NKE icon
292
Nike
NKE
$61.9B
$702K ﹤0.01%
11,897
+1,919
+19% +$104K
AMPH icon
293
Amphastar Pharmaceuticals
AMPH
$825M
$701K ﹤0.01%
39,250
+101
+0.3% +$1.6K
NOC icon
294
Northrop Grumman
NOC
$77B
$698K ﹤0.01%
2,720
+118
+5% +$29.5K
PDLI
295
DELISTED
PDL BioPharma, Inc.
PDLI
$696K ﹤0.01%
281,646
+25,472
+10% +$58.6K
REGN icon
296
Regeneron Pharmaceuticals
REGN
$68.8B
$691K ﹤0.01%
1,407
+135
+11% +$59.1K
MA icon
297
Mastercard
MA
$477B
$688K ﹤0.01%
5,667
-510
-8% -$60.5K
XOM icon
298
ExxonMobil
XOM
$651B
$683K ﹤0.01%
8,459
+912
+12% +$74.6K
CGNX icon
299
Cognex
CGNX
$10.3B
$679K ﹤0.01%
16,002
+924
+6% +$41K
SBUX icon
300
Starbucks
SBUX
$118B
$679K ﹤0.01%
11,643
+1,899
+19% +$115K

Similar funds

ALPS Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, ALPS Advisors held 806 positions worth $14.3B, down 1.2% from $14.5B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

ALPS Advisors's Q2 2017 filing shows 78 new, 577 increased, 108 reduced and 39 closed positions. Its largest new stake was Brookfield: 2,292,089 shares worth $32.1M. The largest sale was Energy Transfer Partners L.p., an estimated $1.04B.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Financials and Materials.

  • ALPS Advisors's largest Q2 2017 buy was Brookfield: 2,292,089 shares worth $32.1M.
  • ALPS Advisors added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $659M increase.
  • ALPS Advisors's biggest Q2 2017 reduction was Enterprise Products Partners, cutting an estimated $54.8M.
  • ALPS Advisors fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $1.04B.
  • ALPS Advisors's ten largest holdings make up 51% of its $14.3B portfolio in Q2 2017.
  • ALPS Advisors opened 78 new positions and closed 39 in Q2 2017.
  • ALPS Advisors's portfolio value fell 1.2% quarter-over-quarter to $14.3B.

Based on ALPS Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.